Perspective Therapeutics
Price & Volume
Stats
See more52W Range | $2.30-$19.10 |
Market Cap | $458.2M |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $1.5M |
Revenue Growth (YoY) | 33.7% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.33 |
News
See moreYahoo Finance • last year
Perspective Therapeutics’ VMT-α-NET Protocols Presented at the North American Neuroendocrine Tumor Society (NANETS) 2023 Symposium
Yahoo Finance • last year
Perspective Announces Presentation of Positive Early Clinical Data for VMT-α-NET at the 36th Annual Congress of the European Association of Nuclear Medicine
Yahoo Finance • last year
Perspective Therapeutics to Present Clinical and Preclinical Data at the 36th Annual Congress of the European Association of Nuclear Medicine
Yahoo Finance • last year
Perspective Therapeutics’ Cesium-131 Featured at the American Brachytherapy Society’s Annual Conference
About
CEO | Mr. Johan M. Spoor |
CFO | Mr. Jonathan R. Hunt |
Address | 2401 Elliott Avenue, Seattle, WA, United States, 98121 |
Sector | Healthcare |
Industry | Medical Devices |
Full-Time Employees | 116 |
